Outcomes for females versus males treated with eribulin mesylate for advanced urothelial carcinoma

Current Problems in Cancer · Published 2026-05-07 · DOI 10.1016/j.currproblcancer.2026.101294

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.currproblcancer.2026.101294

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Related articles